Saphetor provides tools for laboratories, hospitals, and life sciences organizations to interpret genomic data for clinical use. Its technology focuses on transforming raw sequencing information into actionable insights for diagnosing genetic conditions and cancers, operating at the intersection of bioinformatics, AI-driven interpretation, and variant classification.
The company's primary offering is the VarSome platform, a suite that integrates over 140 genomic databases with artificial intelligence tools. This platform is designed to support faster and more accurate clinical diagnoses. The company reports a global user community of over 600,000.
Saphetor's work serves the healthcare, life sciences, and clinical diagnostics sectors, with a particular focus on enabling precision medicine. Its geographic presence is global.
